In fact, tPA administration is the only FDA-approved thrombolytic therapy for acute ischemic stroke (The national institute of neurological disorders and stroke rt-PA stroke study group, 1995; Su et al., 2009). The gene discussed is PLAT; the disease is stroke disorder.